Clinical Trials in Georgia

Showing 6481-6500 of 14,426 trials

Formula Tolerance of Term Infants

NCT04915937

To assess the effects of infant formula with oligosaccharides on symptoms of formula intolerance in healthy, term infants

Gastro-Intestinal Tolerance

Abbott Nutrition45 participantsStarted Jul 2021

Phoenix, Arizona, United States • Miami, Florida, United States • Macon, Georgia, United States +9 more locations

COMPLETEDPhase 349 miles

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

NCT04713553

This is a Phase 3, randomized, observer-blind study in healthy individuals. The primary study will evaluate the safety, tolerability, and immunogenicity of the SARS-CoV-2 RNA vaccine candidate (BNT162b2): * As a 30-microgram dose, administered from 1 of 4 manufacturing lots (batches) * As a 20-microgram dose, administered from 1 of the manufacturing lots * As a 2-dose (separated by 21 days) schedule * In people 12 through 50 years of age The booster study will evaluate the safety, tolerability, and immunogenicity of 2 SARS-CoV-2 RNA vaccine candidates (BNT162b2 and BNT162b2.B.1.351): * Each as a 30-microgram dose * Each as a 1-dose booster vaccine, administered approximately 3 months after Dose 2 * In people 18 through 50 years of age

SARS-CoV-2 InfectionCOVID-19

BioNTech SE1,574 participantsStarted Feb 2021

Oakland, California, United States • Milford, Connecticut, United States • Hialeah, Florida, United States +14 more locations

Formula Tolerance of Term Infants

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

Find Trials by Condition in Georgia

Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis

A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma

Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori

Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion

Evaluation of GLR2007 for Advanced Solid Tumors

Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia